Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nasal steroid spray for sleep-disordered breathing in children
2013-004620-10Phase 2Completed
- Sponsor
- Johan Hellgren
- Start
- Oct 2014
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in sleep disordered breathing (SDB) comparing Rhinocort Aqua with Placebo nasal spray (2 arms). Primary endpoint: Change in OSA-18 scores after treatment. Started Oct 2014; status: completed.
02
Drugs
budesonide
03
Conditions
sleep disordered breathing (SDB)
Beyond the preview
Go deeper on 2013-004620-10.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-004620-10.